plain language summary logo Editor's Pick

Effects of multimodal mobile health interventions on cardiovascular risk factor management in patients with diabetes: a systematic review and meta-analysis.

Journal: BMJ open 2025;15(12):e108371

PMID: 41448671

Plain Language Summary

plain language summary logo

People with diabetes are at much higher risk of developing cardiovascular disease (CVD), including heart attacks and strokes. Managing blood sugar, blood pressure, cholesterol, and body weight is essential to reduce this risk. In recent years, mobile health (mHealth) tools, such as smartphone apps, text messaging, wearable trackers, and online coaching, have been used to help patients manage their conditions. However, it has been unclear how effective multimodal mHealth interventions are in improving cardiovascular risk factors in people with diabetes. This study was a systematic review and meta-analysis of randomised controlled trials, which aimed to evaluate the effects of mHealth interventions on CVD risk factors in individuals with diabetes.

The results showed that mHealth interventions significantly improved several important health markers. These included reductions in glycated haemoglobin (HbA1c, a long-term measure of blood sugar control) and systolic and diastolic blood pressure, and, in some cases, improvements in cholesterol levels, exercise levels, and body weight. Interventions combining education, self-monitoring, feedback from healthcare professionals, and behavioural support tended to yield greater improvements than single-component digital tools.

It was concluded that mHealth interventions can help improve several cardiovascular risk factors in people with diabetes. Healthcare professionals can use these findings to support the integration of structured digital health programmes alongside standard care.

Expert Review

Reviewer: Michelle Weech
6th May 2026
plain language summary logo

Conflict of interest

None

Take home message

  • A robust systematic review and meta-analysis was conducted.

  • Findings demonstrated that multimodal mHealth interventions are effective in improving cardiovascular disease risk factors in people living with diabetes compared with standard care.

  • Authors concluded that multimodal mHealth interventions are a valuable addition to optimise standard diabetes care in the community.

Evidence category

A: Meta-analyses, position-stands, randomized-controlled trials (RCTs)

Summary review

Introduction

  • Mobile health (mHealth) interventions are promising approaches for managing cardiovascular disease (CVD) risk factors.

  • Multimodal interventions are defined as incorporating at least three components, e.g. mobile apps, remote biomarker monitoring, wearable devices, video consultations and/or SMS reminders.

  • This systematic review and meta-analysis evaluated multimodal mHealth interventions on managing CVD risk factors in adults living with diabetes.

Methods

  • A systematic literature search identified randomised, controlled trials (RCTs) in adults living with diabetes (type unspecified) that compared multimodal mHealth interventions (duration: at least 3 months) with standard care.

  • The authors searched MEDLINE, Web of Science, Embase, Cochrane Library, and CINAHL for articles published between January 2010 and December 2024.

  • Pooled effect sizes, considering heterogeneity across studies, were expressed as weighted mean differences, or odds ratios (OR) for categorical variables.

  • Meta-regression was conducted for haemoglobin A1c (HbA1c), low-density lipoprotein cholesterol (LDL-C), total cholesterol, and physical activity participation against covariates (risk of bias, intervention duration, age, male gender, geographical region).

Results

  • The search identified 17 RCTs with 2946 participants.

  • Multimodal mHealth interventions significantly reduced HbA1c (−0.38%; p<0.0001), fasting glucose (−14.1 mg/dL; p<0.0001), systolic blood pressure (−1.30 mmHg; p=0.0021), LDL-C (−6.07 mg/dL; p=0.0004), total cholesterol (−5.40 mg/dL; p=0.0177) and triglycerides (−6.50 mg/dL; p=0.0383), and increased physical activity participation (OR=3.41; p=0.0259) versus standard care.

  • Body mass index, diastolic blood pressure, high-density lipoprotein cholesterol and smoking cessation did not differ between groups.

  • Longer interventions did not appear to produce larger HbA1c reductions.

Conclusion

  • Multimodal mHealth interventions are effective strategies for improving several key CVD risk factors, including glycaemic control, blood pressure, lipid profiles and physical activity levels in people living with diabetes.

Clinical practice applications

Multimodal mHealth interventions, including mobile apps, remote biomarker monitoring, wearable devices, video consultations and/or SMS reminders can be low cost and used at scale, and evidence suggests they are a valuable addition to conventional diabetes care.

Considerations for future research

Since multimodal mHealth interventions typically assume a certain level of digital skills and literacy, the authors acknowledge these findings may not be generalisable to all groups, such as older adults and those with lower literacy. They recommended that equitable access is a focus for future mHealth interventions, such as the inclusion of voice-based apps and simplified wearables, to “bridge the digital divide”.

plain language summary logo
Expert reviews are written by nutrition professionals and academics with advanced qualifications to provide a critical appraisal of the article and implications for practice. Each review is peer-reviewed by a member of the NED Editorial Board. Find out more about our NED Expert Reviewers here.

Abstract

OBJECTIVES

Diabetes mellitus significantly increases the risk of cardiovascular disease (CVD). While mobile health (mHealth) interventions show promise, there is limited evidence on the efficacy of multimodal approaches for managing comprehensive CVD risk factors. This systematic review and meta-analysis aimed to evaluate the effectiveness of multimodal mHealth interventions in managing CVD risk factors in patients with diabetes.

DESIGN

Systematic review and meta-analysis of randomised controlled trials (RCTs), reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines.

DATA SOURCES

MEDLINE, Web of Science, Embase, Cochrane Library and CINAHL were searched for RCTs published from January 2010 to December 2024.

ELIGIBILITY CRITERIA

RCTs involving adults (≥18 years) with diabetes who received multimodal mHealth interventions (incorporating at least three components such as mobile apps, remote monitoring and SMS reminders) for ≥3 months, compared with standard care, were included.

DATA EXTRACTION AND SYNTHESIS

Two independent reviewers screened records, extracted data and assessed the risk of bias using the original Cochrane risk of bias (RoB) tool. Perform effect size pooling using R V.4.4.3 and report the corresponding results, taking into account the observed heterogeneity.

RESULTS

Out of 2730 screened records, 17 RCTs (n=2946 participants) met the inclusion criteria. Multimodal mHealth interventions significantly reduced haemoglobin A1c (HbA1c) (weighted mean difference (WMD) = -0.38%, 95% CI -0.52 to -0.24; p<0.0001), fasting glucose (WMD=-14.10 mg/dL, 95% CI -20.89 to -7.30; p<0.0001), systolic blood pressure (WMD=-1.30 mm Hg, 95% CI -2.12 to -0.47; p=0.0021), low-density lipoprotein cholesterol (WMD=-6.07 mg/dL, 95% CI -9.45 to -2.68; p=0.0004), total cholesterol (WMD=-5.40 mg/dL, 95% CI -9.85 to -0.93; p=0.0177) and triglycerides (WMD=-6.50 mg/dL, 95% CI -12.65 to -0.35; p=0.0383). The interventions also increased physical activity participation (OR=3.41, 95% CI 1.16 to 10.05; p=0.0259). No significant effects were observed on body mass index, diastolic blood pressure, high-density lipoprotein cholesterol, smoking cessation or adverse event rates.

CONCLUSIONS

Multimodal mHealth interventions are effective in improving several key cardiometabolic parameters, including glycaemic control, blood pressure, lipid profiles and physical activity levels in patients with diabetes. These interventions represent a promising strategy for comprehensive CVD risk factor management in this population.

PROSPERO REGISTRATION NUMBER

CRD420251050970. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251050970.

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.

Address: Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.; Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.